Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection.
about
Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections?Ceftaroline-Fosamil efficacy against methicillin-resistant Staphylococcus aureus in a rabbit prosthetic joint infection model.Vancomycin resistance: occurrence, mechanisms and strategies to combat it.Poly(trimethylene carbonate) as a carrier for rifampicin and vancomycin to target therapy-recalcitrant staphylococcal biofilms.Teicoplanin-containing cement spacers for treatment of experimental Staphylococcus aureus joint prosthesis infection.Ceftobiprole efficacy in vitro against Panton-Valentine leukocidin production and in vivo against community-associated methicillin-resistant Staphylococcus aureus osteomyelitis in rabbitsEmerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections.Foreign body infections due to Staphylococcus epidermidis.Daptomycin in bone and joint infections: a review of the literature.Rifampin combination therapy for nonmycobacterial infections.Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus.Emergency 1-stage anterior approach for cervical spine infection complicated by epidural abscess.
P2860
Q34252915-07631B8B-DDD7-43A5-908F-D9CFC8AB65DCQ34596373-1020211E-EC0F-4DA8-B91F-5393EB78481EQ35143886-9F3B4793-BEBA-49F9-AC4C-E43799CCDF96Q35923715-882478FF-4D2C-4D2B-A1BA-F5D8EF69830CQ36048436-F4F47C08-8681-4A34-8C61-1B29A9676248Q36396146-B900A964-923A-4462-A9CC-F2D665A030A7Q36718474-DC2244E2-85B8-4A8B-BFCD-2CE49C347BD0Q37249440-7955269C-D983-47B6-BA0F-3A5DB8F624B3Q37319460-185B7426-2A55-42CF-B8D4-3A167827CE77Q37672039-9540D859-D91A-4F34-A98A-01D7BEFEF2F4Q38627239-24C23C4F-415E-4C2F-823F-01926605F481Q40154965-259C4B97-5104-465E-99D3-400414817BC7
P2860
Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Combination of quinupristin-da ...... us joint prosthesis infection.
@en
Combination of quinupristin-dalfopristin
@nl
type
label
Combination of quinupristin-da ...... us joint prosthesis infection.
@en
Combination of quinupristin-dalfopristin
@nl
prefLabel
Combination of quinupristin-da ...... us joint prosthesis infection.
@en
Combination of quinupristin-dalfopristin
@nl
P2093
P2860
P1476
Combination of quinupristin-da ...... us joint prosthesis infection.
@en
P2093
Anne-Claude Crémieux
Azzam Saleh-Mghir
Claudette Muller-Serieys
Céline Feger
Farid Ismael
Françoise Lemaitre
Laurent Massias
Nourdine Ameur
Rémy Bléton
P2860
P304
P356
10.1128/AAC.46.4.1122-1124.2002
P407
P577
2002-04-01T00:00:00Z